Neurocrine Biosciences Inc financial data

Symbol
NBIX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6027 Edgewood Bend Court, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 248 % -18.3%
Quick Ratio 5.15 % -35.7%
Debt-to-equity 43.8 % +10.7%
Return On Equity 17.5 % +334%
Return On Assets 12.1 % +321%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101 M shares +3.14%
Common Stock, Shares, Outstanding 101 M shares +3.18%
Entity Public Float 7.9 B USD -2.44%
Common Stock, Value, Issued 100 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 99.8 M shares +2.78%
Weighted Average Number of Shares Outstanding, Diluted 104 M shares +6.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.98 B USD +24%
Costs and Expenses 1.52 B USD +3.46%
Operating Income (Loss) 464 M USD +253%
Nonoperating Income (Expense) 5.5 M USD -694%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 470 M USD +427%
Income Tax Expense (Benefit) 100 M USD +298%
Net Income (Loss) Attributable to Parent 370 M USD +478%
Earnings Per Share, Basic 3.78 USD/shares +464%
Earnings Per Share, Diluted 3.68 USD/shares +484%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 396 M USD +282%
Accounts Receivable, after Allowance for Credit Loss, Current 451 M USD +15.1%
Inventory, Net 37.2 M USD +11.4%
Other Assets, Current 101 M USD -11.2%
Assets, Current 1.8 B USD +25.6%
Deferred Income Tax Assets, Net 378 M USD +12.1%
Property, Plant and Equipment, Net 75.3 M USD +19.9%
Operating Lease, Right-of-Use Asset 271 M USD +221%
Intangible Assets, Net (Excluding Goodwill) 34.3 M USD -7.8%
Goodwill 5.7 M USD +1.79%
Other Assets, Noncurrent 50.9 M USD +104%
Assets 3.47 B USD +47.1%
Employee-related Liabilities, Current 42.6 M USD
Liabilities, Current 713 M USD +90.6%
Accrued Income Taxes, Noncurrent 101 M USD
Operating Lease, Liability, Noncurrent 253 M USD +180%
Other Liabilities, Noncurrent 121 M USD +192%
Liabilities 1.09 B USD +60.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 3.3 M USD
Retained Earnings (Accumulated Deficit) -114 M USD +76.5%
Stockholders' Equity Attributable to Parent 2.39 B USD +41.7%
Liabilities and Equity 3.47 B USD +47.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 130 M USD
Net Cash Provided by (Used in) Financing Activities 69.9 M USD +752%
Net Cash Provided by (Used in) Investing Activities -55 M USD -30.6%
Common Stock, Shares Authorized 220 M shares 0%
Common Stock, Shares, Issued 101 M shares +3.18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 145 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 404 M USD +262%
Deferred Tax Assets, Valuation Allowance 88.9 M USD +32.7%
Deferred Tax Assets, Gross 530 M USD +30.7%
Operating Lease, Liability 288 M USD +167%
Depreciation 5.3 M USD +29.3%
Payments to Acquire Property, Plant, and Equipment 11.2 M USD +31.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 376 M USD +432%
Lessee, Operating Lease, Liability, to be Paid 377 M USD +184%
Property, Plant and Equipment, Gross 154 M USD +23.1%
Operating Lease, Liability, Current 35 M USD +98.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 34 M USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year One 34.7 M USD +99.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 89.5 M USD +259%
Lessee, Operating Lease, Liability, to be Paid, Year Three 34.8 M USD +122%
Deferred Tax Assets, Operating Loss Carryforwards 36.4 M USD +32.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 121 M USD +43.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 35.6 M USD +123%
Operating Lease, Payments 6.1 M USD +38.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 900 K USD 0%
Interest Expense 4.6 M USD -17.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%